Antoni Ribas

Antoni Ribas i Piera (27 October 1935 – 3 October 2007) was a Catalan Spanish film director and screenwriter. He directed 15 films between 1966 and 2007. His 1973 film ''La otra imagen'' was entered into the 1973 Cannes Film Festival. Provided by Wikipedia
Showing 1 - 20 results of 45 for search 'Antoni Ribas', query time: 0.06s Refine Results
  1. 1
    Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

    Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy by Zeynep Eroglu, Antoni Ribas

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Preparation of peptide–MHC and T-cell receptor dextramers by biotinylated dextran doping

    Preparation of peptide–MHC and T-cell receptor dextramers by biotinylated dextran doping by Michael T. Bethune, Begoña Comin-Anduix, Yu-Hsien Hwang Fu, Antoni Ribas, David Baltimore

    Published 2017-03-01
    Get full text
    Article
  3. 3
    Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

    Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy by Arun Singh, Antoni Ribas, Theodore Scott Nowicki, Katie M Campbell, Anusha Kalbasi, Maneesha Thaker, Egmidio Medina

    Published 2022-03-01
    Get full text
    Article
  4. 4
    Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance.

    Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance. by Yapeng Su, Marcus Bintz, Yezi Yang, Lidia Robert, Alphonsus H C Ng, Victoria Liu, Antoni Ribas, James R Heath, Wei Wei

    Published 2019-06-01
    Get full text
    Article
  5. 5
    Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

    Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512. by Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak

    Published 2012-01-01
    Get full text
    Article
  6. 6
    A topical BRAF inhibitor (LUT-014) for treatment of radiodermatitis among women with breast cancerCapsule Summary

    A topical BRAF inhibitor (LUT-014) for treatment of radiodermatitis among women with breast cancerCapsule Summary by Sanford Katz, MD, Doug Ciuba, MD, Antoni Ribas, MD, PhD, Noa Shelach, PhD, Galit Zelinger, BS, Briana Barrow, BS, Benjamin W. Corn, MD

    Published 2024-06-01
    Get full text
    Article
  7. 7
    Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials

    Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled a... by Paolo A. Ascierto, Antoni Ribas, James Larkin, Grant A. McArthur, Karl D. Lewis, Axel Hauschild, Keith T. Flaherty, Edward McKenna, Qian Zhu, Yong Mun, Brigitte Dréno

    Published 2020-08-01
    Get full text
    Article
  8. 8
    Interleukin 32 expression in human melanoma

    Interleukin 32 expression in human melanoma by Helicia Paz, Jennifer Tsoi, Anusha Kalbasi, Catherine S. Grasso, William H. McBride, Dörthe Schaue, Lisa H. Butterfield, Deena M. Maurer, Antoni Ribas, Thomas G. Graeber, James S. Economou

    Published 2019-04-01
    Get full text
    Article
  9. 9
    Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

    Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis by Selena Ferrian, Candace C. Liu, Erin F. McCaffrey, Rashmi Kumar, Theodore S. Nowicki, David W. Dawson, Alex Baranski, John A. Glaspy, Antoni Ribas, Sean C. Bendall, Michael Angelo

    Published 2021-10-01
    Get full text
    Article
  10. 10
    Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells

    Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells by Jiajun Du, Yapeng Su, Chenxi Qian, Dan Yuan, Kun Miao, Dongkwan Lee, Alphonsus H. C. Ng, Reto S. Wijker, Antoni Ribas, Raphael D. Levine, James R. Heath, Lu Wei

    Published 2020-09-01
    Get full text
    Article
  11. 11
    Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

    Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade by Arun Singh, Begoña Comin-Anduix, Antoni Ribas, Beata Berent-Maoz, Theodore Scott Nowicki, Luke Frankiw, Cole Peters, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero

    Published 2023-05-01
    Get full text
    Article
  12. 12
    Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.

    Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. by Mohammad Atefi, Erika von Euw, Narsis Attar, Charles Ng, Connie Chu, Deliang Guo, Ramin Nazarian, Bartosz Chmielowski, John A Glaspy, Begonya Comin-Anduix, Paul S Mischel, Roger S Lo, Antoni Ribas

    Published 2011-01-01
    Get full text
    Article
  13. 13
    Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death

    Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death by Nicholas A Graham, Martik Tahmasian, Bitika Kohli, Evangelia Komisopoulou, Maggie Zhu, Igor Vivanco, Michael A Teitell, Hong Wu, Antoni Ribas, Roger S Lo, Ingo K Mellinghoff, Paul S Mischel, Thomas G Graeber

    Published 2012-06-01
    Get full text
    Article
  14. 14
    596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy

    596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 thera... by Antoni Ribas, Mohammed Milhem, Diwakar Davar, Patricia LoRusso, Zeynep Eroglu, Martin Gutierrez, Arindam Dhar, Carlos Becerra, Brian Di Pace, Tianli Wang, Hailei Zhang, Srimoyee Ghosh, Shyam Srivats, Theo Borgovan, Angela Waszak

    Published 2023-11-01
    Article
  15. 15
    Correction: ERK mediates interferon gamma-induced melanoma cell death

    Correction: ERK mediates interferon gamma-induced melanoma cell death by Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M. Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas

    Published 2024-02-01
    Get full text
    Article
  16. 16
    ERK mediates interferon gamma-induced melanoma cell death

    ERK mediates interferon gamma-induced melanoma cell death by Ameya Champhekar, Rachel Heymans, Justin Saco, Guillem Turon Font, Cynthia Gonzalez, Anne Gao, John Pham, June Lee, Ryan Maryoung, Egmidio Medina, Katie M. Campbell, Daniel Karin, David Austin, Robert Damioseaux, Antoni Ribas

    Published 2023-10-01
    Get full text
    Article
  17. 17
    Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.

    Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. by Todd M Brusko, Richard C Koya, Shirley Zhu, Michael R Lee, Amy L Putnam, Stephanie A McClymont, Michael I Nishimura, Shuhong Han, Lung-Ji Chang, Mark A Atkinson, Antoni Ribas, Jeffrey A Bluestone

    Published 2010-07-01
    Get full text
    Article
  18. 18
    Natural killer T cells in advanced melanoma patients treated with tremelimumab.

    Natural killer T cells in advanced melanoma patients treated with tremelimumab. by F Javier Ibarrondo, Otto O Yang, Thinle Chodon, Earl Avramis, Yohan Lee, Hooman Sazegar, Jason Jalil, Bartosz Chmielowski, Richard C Koya, Ingrid Schmid, Jesus Gomez-Navarro, Beth D Jamieson, Antoni Ribas, Begoña Comin-Anduix

    Published 2013-01-01
    Get full text
    Article
  19. 19
    PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

    PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma by Antoni Ribas, Alain Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H. Miller, Katie M. Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert

    Published 2020-12-01
    Get full text
    Article
  20. 20
    Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects.

    Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects. by Helena Escuin-Ordinas, Yining Liu, Lu Sun, Willy Hugo, Robert Dimatteo, Rong Rong Huang, Paige Krystofinski, Ariel Azhdam, Jordan Lee, Begoña Comin-Anduix, Alistair J Cochran, Roger S Lo, Tatiana Segura, Philip O Scumpia, Antoni Ribas

    Published 2021-01-01
    Get full text
    Article

Search Tools: